| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 11/19/2008 | CN101306128A Decoction for treating otitis media suppurativa acuta |
| 11/19/2008 | CN101306125A Decoction for treating acute conjunctivitis |
| 11/19/2008 | CN101306121A Steaming and washing medicament for treating acute conjunctivitis |
| 11/19/2008 | CN101306102A Ear drops for treating otitis media suppurativa acuta |
| 11/19/2008 | CN101305777A Gingko pulp paste |
| 11/19/2008 | CN100434421C Substituted propane-1,3-diamine derivatives and the pharmaceutical use |
| 11/18/2008 | US7453010 trans-N-{5-[((2S)-3-{[4-(1,1'-Biphenyl-4-yl)cyclohexyl]amino}-2-hydroxypropyl)oxy]-2-hydroxyphenyl}methanesulfonamide; beta 3 receptor agonists; antiinflammtory agent; irritable bowel syndrome; obesity, diabeties, glaucoma, dysmenorrheal, depression, urinary incontinence, lipolysis or cicatrizing |
| 11/18/2008 | US7452929 comprise a polymer that is inherently radiopaque or a polymer that has been made radiopaque by the addition of an additive that provides radiopaque characteristics |
| 11/18/2008 | US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/18/2008 | US7452904 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 11/18/2008 | US7452884 Methods for inhibiting angiogenesis |
| 11/18/2008 | CA2402652C Viscoelastics for use in middle ear surgery |
| 11/18/2008 | CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 11/18/2008 | CA2383222C Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 11/18/2008 | CA2362281C Combinations for the treatment of diseases involving angiogenesis |
| 11/18/2008 | CA2352275C Il-5 inhibiting 6-azauracil derivatives |
| 11/13/2008 | WO2008137496A1 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same |
| 11/13/2008 | WO2008137236A2 Treatment of age-related macular degeneration using inhibitors of complement factor d |
| 11/13/2008 | WO2008136707A1 Ophthalmological gel and a method for the use thereof |
| 11/13/2008 | WO2008136444A1 Fused heterocyclic derivative |
| 11/13/2008 | WO2008136393A1 Crystal of lactam compound, and method for production thereof |
| 11/13/2008 | WO2008136382A1 Bicyclic compound and pharmaceutical use thereof |
| 11/13/2008 | WO2008136034A2 Ophthalmic compositions for the treatment of ocular hypertension and glaucoma |
| 11/13/2008 | WO2008135984A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level |
| 11/13/2008 | WO2008135661A2 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
| 11/13/2008 | WO2007030307A3 Method of treating glaucoma |
| 11/13/2008 | US20080281000 Crosslinked gels; polysaccharides grafted with alkoxyether amides; used in hydraulic fracturing of oil wells and as dispersants in paint and dye industeries; cosmetics; drug delivery carriers |
| 11/13/2008 | US20080280987 Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases |
| 11/13/2008 | US20080280958 Administering a phosphodiesterase inhibitor; bioavailability; skin disorders; respiratory system disorders; using roflumilast |
| 11/13/2008 | US20080280934 Porphyrin ring compound containing cyanovinyl group; reacted with Vilsmeier reagent,complexed with metal ion in prsence of an acid and oxidizer; skin disorders; antiinflammatory agents; anticancer agents; antitumor agents; vascular disorders, vision defects, urogenital system disorders; immunology |
| 11/13/2008 | US20080280914 Intravenous Formulations of Pde Inhibitors |
| 11/13/2008 | US20080280853 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same |
| 11/13/2008 | US20080280825 Protective BF protein, protective C2 protein; sample, diagnosis, prophylaxis, therapy of dysregulation of complement mediated disease; membrane proliferative glomerulonephritis |
| 11/13/2008 | US20080279913 Reduces oxidative stresses of the eye; using iron chelate compound |
| 11/13/2008 | US20080279912 Use of Cis-Epoxyeicosatrienoic Acids And Inhibitors of Soluble Epoxide Hydrolase to Alleviate Eye Disorders |
| 11/13/2008 | US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells |
| 11/13/2008 | US20080276568 Building structure and components thereof |
| 11/13/2008 | CA2689608A1 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
| 11/13/2008 | CA2684703A1 Bicyclic compound and pharmaceutical use thereof |
| 11/13/2008 | CA2680833A1 Treatment of age-related macular degeneration using inhibitors of complement factor d |
| 11/12/2008 | EP1990413A1 Screening method for candidate drugs |
| 11/12/2008 | EP1990343A2 Azaindoles |
| 11/12/2008 | EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators |
| 11/12/2008 | EP1990060A1 Remedy for disease associated with choroidal angiogenesis |
| 11/12/2008 | EP1990053A1 Pharmaceutical composition for enhancing adiponectin production |
| 11/12/2008 | EP1988892A2 Modulators of muscarinic receptors |
| 11/12/2008 | EP1988889A2 Compositions and methods for treatment of ophthalmic diseases and disorders |
| 11/12/2008 | EP1988885A2 Combination of organic compounds |
| 11/12/2008 | EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 11/12/2008 | EP1444349B1 Polypeptides of moraxella (branhamella) catarrhalis |
| 11/12/2008 | EP1424894B1 Inhibition of pathological angiogenesis in vivo |
| 11/12/2008 | EP1392831B1 Moraxella(branhamella) catarrhalis antigens |
| 11/12/2008 | EP1365771B9 Method of treating certain eye diseases |
| 11/12/2008 | EP1259615B1 Antibodies against eotaxin and their use |
| 11/12/2008 | CN101304742A Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy |
| 11/12/2008 | CN101302515A Human antibodies that bind human TNF(alpha) |
| 11/12/2008 | CN101301417A Powder for treating circumscribed external otitis |
| 11/12/2008 | CN101301400A Camellia functional instant formulation and preparation thereof |
| 11/12/2008 | CN101301399A Six ingredients chrysanthemum pearl capsules for improving vision |
| 11/12/2008 | CN101301358A Lotion for treating ulcerative blepharitis |
| 11/12/2008 | CN101301317A Compound abalone shell calcium tablet |
| 11/12/2008 | CN101301014A Cassia seed black tea and method for processing the cassia seed black tea |
| 11/12/2008 | CN100432070C Novel sulfamides and their use as endothelin receptor antagonists |
| 11/12/2008 | CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same |
| 11/12/2008 | CN100431601C Cyclosporine microball preparation for treating endophthalmitis |
| 11/12/2008 | CN100431544C Formulations of glucocorticoids to treat pathologic ocular angiogenesis |
| 11/11/2008 | US7449484 angiogenesis inhibitor; Tie2 receptor kinase inhibitors; 2-tert-Butyl-4-naphthalen-2-yl-5-pyridin-4-yl-imidazole;2-tert-Butyl-4-(6-Ethoxynaphthalen-2-yl)-5-pyridin-4-yl-imidazole;4-(2-tert-Butyl-5-(6-methoxy-naphthalen-2-yl)-3H-imidazol-4-yl)-pyridine; etc. |
| 11/06/2008 | WO2008134644A1 High viscosity macromolecular compositions for treating ocular conditions |
| 11/06/2008 | WO2008133928A2 Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders |
| 11/06/2008 | WO2008133198A1 Neurite formation promoter |
| 11/06/2008 | WO2008133129A1 Therapeutic agent for glaucoma comprising adenosine a2a receptor agonist as active ingredient |
| 11/06/2008 | WO2008133021A1 COMPOSITION FOR AMELIORATING OPTIC NERVE DISORDER COMPRISING PROSTAGLANDIN F2α COMPOUND AS ACTIVE INGREDIENT |
| 11/06/2008 | WO2008104856A3 A synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case of glaucoma |
| 11/06/2008 | WO2008033924A3 Methods and compositions for targeted delivery of therapeutic agents |
| 11/06/2008 | US20080275134 Retinylamine derivatives; preventing photoreceptor degeneration |
| 11/06/2008 | US20080275133 Local Administration of Retinoids to Treat Deficiencies in Dark Adaptation |
| 11/06/2008 | US20080275118 For treating dyed/colored hair without loss of color |
| 11/06/2008 | US20080275059 Novel physiologically active substances |
| 11/06/2008 | US20080275034 having a calpain inhibiting activity and an activity which traps the reactive oxygen species (ROS); for protecting acoustic hair cells; |
| 11/06/2008 | US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
| 11/06/2008 | US20080275000 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same |
| 11/06/2008 | US20080274999 Cosmetics; low molecular weight; therapy for osteoarthritis |
| 11/06/2008 | US20080274983 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases |
| 11/06/2008 | US20080274546 Artificial physiological salt solution and manufacturing method for same |
| 11/06/2008 | US20080274207 packaging solution that maintains a consistent level of antimicrobial metal salt; little of the antimicrobial metal salt is lost during autoclaving and storing the contact lens |
| 11/06/2008 | US20080274045 Imaging, diagnosis and treatment of disease |
| 11/06/2008 | CA2685522A1 High viscosity macromolecular compositions for treating ocular conditions |
| 11/06/2008 | CA2684561A1 Neurite formation promoter |
| 11/06/2008 | CA2679658A1 Fusion proteins binding to growth factors |
| 11/05/2008 | EP1988102A1 Growth factor homolog ZVEGF3 |
| 11/05/2008 | EP1988081A1 Binding inhibitor of sphingosine-1-phosphate |
| 11/05/2008 | EP1987064A1 Domain antibody construct |
| 11/05/2008 | EP1986683A2 Compositions and methods for effecting controlled posterior vitreous detachment |
| 11/05/2008 | EP1986666A1 Novel method and compositions for treatment of tinnitus |
| 11/05/2008 | EP1986653A1 The treatment of ocular conditions and the systemic side-effects of glucocorticoids |
| 11/05/2008 | EP1986627A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
| 11/05/2008 | EP1385514B1 Spiroindene and spiroindane compounds |
| 11/05/2008 | EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof |
| 11/05/2008 | EP1216247B1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 11/05/2008 | EP1140172B1 The prevention and treatment for retinal ischemia and edema |